Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study is the first clinical trial using sodium oxybate for the treatment of REM sleep
behavior disorder (RBD). Sodium oxybate is a drug approved by FDA for the treatment of
narcolepsy which has been used "off label" to treat patients with severe RBD. This drug has
shown to be effective and well tolerated in patients with RBD (Shneerson, 2009; Liebenthal,
2016; Moghadam, 2017).